Abiopharma

IceCures ProSense® Featured at Japanese Breast Cancer Society Conference: Updated Positive Clinical Data Shows 99% Recurrence Free Rate with Cryoablation

Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025

New Form 6-K - BioNTech SE Filed: 2025-07-25 AccNo: 0001776985-25-000047 Size: 223 KB

Moderna - EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Modernas COVID-19 mRNA Vaccine Targeting the SARS-CoV-2 Variant LP.8.1

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Sarepta Therapeutics Acknowledges CHMP Negative Opinion for ELEVIDYS in the European Union

New Form 25-NSE - Verve Therapeutics, Inc. Filed: 2025-07-25 AccNo: 0001354457-25-000739 Size: 2 KB

Intelligent Bio Solutions Inc. - Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

Schrödinger, Inc. - Schrödinger to Announce Second Quarter 2025 Financial Results on August 6

Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds

New Form DEFA14A - ZimVie Inc. Filed: 2025-07-25 AccNo: 0001193125-25-164864 Size: 32 KB

New Form 8-K - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070554 Size: 564 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 6-K - GSK plc Filed: 2025-07-25 AccNo: 0001654954-25-008470 Size: 3 MB

New Form 424B5 - OMEROS CORP Filed: 2025-07-25 AccNo: 0001104659-25-070553 Size: 605 KB

New Form 8-K - CareCloud, Inc. Filed: 2025-07-25 AccNo: 0001493152-25-011403 Size: 291 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits